Evidence map›Paper›PMID 40491049›Full record

Observational studyRenal failure2025

Longitudinal kidney outcomes in surviving COVID-19 patients in Africa: a prospective Congolese single-center cohort study.

Yannick Mayamba Nlandu, Jean-Robert Rissassi Makulo, Marie Essig, Yannick Mompango Engole, Marie-France Ingole Mboliasa, Aliocha Natuhoyila Nkodila, Vieux Momeme Mokoli, Clarisse Nsenga Nkondi, Augustin Luzayadio Longo, François Musungayi Kajingulu and 8 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yannick Mayamba NlanduNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Jean-Robert Rissassi MakuloNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Marie EssigNephrology Department, Ambroise Paré Hospital, AP-HP University Paris-Saclay, Boulogne-Billancourt, France.
Yannick Mompango EngoleNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Marie-France Ingole MboliasaNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Aliocha Natuhoyila NkodilaDepartment of Family Medicine and Primary Care, Protestant University in Congo, Kinshasa, Democratic Republic of Congo.
Vieux Momeme MokoliNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Clarisse Nsenga NkondiNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Augustin Luzayadio LongoNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
François Musungayi KajinguluNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Cédric Kabemba IlungaNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Chantal Vuvu ZingaNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Evariste Mukendi KadimaNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Justine Busanga BukabauNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Steve Mundeke AhukaDepartment of Medical Microbiology and Virology, National Institute of Biomedical Research (INRB), Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Aimé LumakaCentre for Human Genetics, Department of Pediatrics, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Nazaire Mangani NsekaNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Ernest Kiswaya SumailiNephrology Unit, Departement of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of Congo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to determine kidney outcomes and associated factors in COVID-19 patients discharged from intensive care unit (ICU) in an African setting.

methodsIn a prospective observational single-center cohort study, we compared the rate of decline in eGFRcr and the incidence of CKD between COVID-19 patients with and without AKI after discharge from ICU. Kidney function decline (KFD) and chronic kidney disease (CKD) during 2 years of follow-up were defined as eGFR decline ≥ 30% and eGFR less than 60 mL/min/1.73 m

resultsThe incidence of KFD and CKD at two years of follow-up was 23% and 0.73 per 100 patient months (P-M), respectively. Patients with COVID-AKI had a greater decline in eGFR (-11.09 mL/min/1.73 m

conclusionKFD and CKD are common in COVID-19 survivors. AKI was associated with both KFD and CKD after ICU discharge. Kidney care after COVID-19 needs to be organized in the context of AKI.

Indexed as

Acute Kidney InjuryCOVID-19Renal Insufficiency, ChronicAdultAgedCreatinineFemaleGlomerular Filtration RateHumansIncidenceIntensive Care UnitsLongitudinal StudiesMaleMiddle AgedProspective StudiesRisk FactorsCreatinineAKICKDeGFR slopekidney outcomeLong-COVID

Identifiers

PMID40491049
PMCPMC12152984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.